Skip to main content
. 2017 Nov 6;2017(11):CD008727. doi: 10.1002/14651858.CD008727.pub4

Schlosser 2016.

Methods Study type: retrospective single‐centre study
Setting: Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
Participants 176 paediatric patients with ALL during maintenance phase of treatment
Interventions Treatment protocol: unknown
Type of glucocorticoid therapy: unknown
Methods of cessation of glucocorticoid therapy: unknown
Outcomes Specific HPA axis function test: unknown
Moment of testing: unknown
Cutoff limits defined by original studies: unknown
Notes This study has not been published in full text (search conducted 12 December 2016) but was presented to the ASPHO 2016 conference. It is not yet clear whether this study is eligible for inclusion in this review.

ALL: acute lymphoblastic leukaemia.

ASPHO: American Society of Pediatric Hematology/Oncology.

HPA: hypothalamic‐pituitary‐adrenal.